引用本文: | 洪浩. 放射性核素偶联药物研发的优势与挑战[J]. 药学进展, 2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001 |
Citation: | HONG Hao. Advantages and Challenges of Radionuclide Coupled Drugs Development[J]. Progress in Pharmaceutical Sciences, 2023, 47(5): 321-323. DOI: 10.20053/j.issn1001-5094.2023.05.001 |